Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
Clinical trial NCT06712407 · RECRUITING
Trial details
- NCT number
- NCT06712407
- Sponsor
- Calliditas Therapeutics AB
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-17
- Primary completion
- 2026-05-29
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.